MedPath
FDA Approval

Diphenoxylate Hydrochloride and Atropine Sulfate

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
RedPharm Drug, Inc.
DUNS: 828374897
Effective Date
January 20, 2022
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Atropine(0.025 mg in 1 1)
Diphenoxylate(2.5 mg in 1 1)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

RedPharm Drug, Inc.

RedPharm Drug, Inc.

828374897

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Diphenoxylate Hydrochloride and Atropine Sulfate

Product Details

NDC Product Code
67296-1241
Application Number
NDA012462
Marketing Category
NDA authorized generic (C73605)
Route of Administration
ORAL
Effective Date
January 20, 2022
AtropineActive
Code: 03J5ZE7KA5Class: ACTIBQuantity: 0.025 mg in 1 1
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
STARCH, CORNInactive
Code: O8232NY3SJClass: IACT
SUCROSEInactive
Code: C151H8M554Class: IACT
ACACIAInactive
Code: 5C5403N26OClass: IACT
SORBITOLInactive
Code: 506T60A25RClass: IACT
TALCInactive
Code: 7SEV7J4R1UClass: IACT
Code: W24OD7YW48Class: ACTIBQuantity: 2.5 mg in 1 1
© Copyright 2025. All Rights Reserved by MedPath